This invention is directed generally to triazolopyridine compounds that generally inhibit p38 kinase, TNF, and/or cyclooxygenase activity. Such triazolopyridine include compounds generally corresponding in structure to the following formula (I): wherein R<sup
申请公布号
WO2006018735(A2)
申请公布日期
2006.02.23
申请号
WO2005IB02868
申请日期
2005.08.08
申请人
PHARMACIA & UPJOHN COMPANY LLC;RUCKER, PAUL, V.;JEROME, KEVIN, DE WAYNE;SELNESS, SHAUN, RAJ;BALDUS, JOHN, EDWARD;XING, LI
发明人
RUCKER, PAUL, V.;JEROME, KEVIN, DE WAYNE;SELNESS, SHAUN, RAJ;BALDUS, JOHN, EDWARD;XING, LI